Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Histone H3 wild-type DIPG/DMG overexpressing EZHIP extend the spectrum diffuse midline gliomas with PRC2 inhibition beyond H3-K27M mutation.

Acta neuropathologica - 1 Jun 2020

Castel David, Kergrohen Thomas, Tauziède-Espariat Arnault, Mackay Alan, Ghermaoui Samia, Lechapt Emmanuèle, Pfister Stefan M, Kramm Christof M, Boddaert Nathalie, Blauwblomme Thomas, Puget Stéphanie, Beccaria Kévin, Jones Chris, Jones David T W, Varlet Pascale, Grill Jacques, Debily Marie-Anne

Abstract excerpt

No abstract is available from the source.

Topics

Join the communities discussing this publication.

Brain Neoplasms
Glioma
Glutamates
Histones
Mutation
Oncogene Proteins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Transcription Factors

Source

Identifiers

PMID: 32193787
DOI: 10.1007/s00401-020-02142-w

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Histone H3 wild-type DIPG/DMG overexpressing EZHIP extend the spectrum diffuse midline gliomas with PRC2 inhibition beyond H3-K27M mutation.PMID 32193787Read ↗

EZHIP's role in diffuse midline glioma: echoes of oncohistones?Semantic proximity Read ↗

H3K27-Altered Diffuse Midline Glioma of the Brainstem: From Molecular Mechanisms to Targeted Interventions.Semantic proximity Read ↗

Epigenetic mechanisms and therapeutic advances in diffuse midline glioma (Review).Semantic proximity Read ↗

H3 K27M and EZHIP Impede H3K27-Methylation Spreading by Inhibiting Allosterically Stimulated PRC2.Semantic proximity Read ↗

H3F3A K27M mutations drive a repressive transcriptome by modulating chromatin accessibility independent of H3K27me3 in Diffuse Midline Glioma.Semantic proximity Read ↗

Histone H3-wild type diffuse midline gliomas with H3K27me3 loss are a distinct entity with exclusive EGFR or ACVR1 mutation and differential methylation of homeobox genes.Semantic proximity Read ↗

H3 K27M and EZHIP impede H3K27-methylation spreading by inhibiting allosterically stimulated PRC2Semantic proximity Read ↗

How to treat histone 3 altered gliomas: molecular landscape and therapeutic developments.Semantic proximity Read ↗

Emerging Advances in Combinatorial Treatments of Epigenetically Altered Pediatric High-Grade H3K27M GliomasSemantic proximity Read ↗

Advanced Pediatric Diffuse Pontine Glioma Murine Models Pave the Way towards Precision MedicineSemantic proximity Read ↗

H3F3A K27M Mutations Drives a Repressive Transcriptome by Modulating Chromatin Accessibility, Independent of H3K27me3 in Diffuse Midline GliomaSemantic proximity Read ↗

Advanced Pediatric Diffuse Pontine Glioma Animal Models Pave the Way Towards Precision MedicineSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.